Linux Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 9.86 Cr
as on 23-10-2024
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.00 Cr
as on 23-10-2024
- Satisfied Charges ₹ 6.50 Cr
as on 23-10-2024
- Revenue 58.15%
(FY 2023)
- Profit 118.95%
(FY 2023)
- Ebitda 122.80%
(FY 2023)
- Net Worth 1.23%
(FY 2023)
- Total Assets 81.75%
(FY 2023)
About Linux Life Sciences
The Corporate was formerly known as Dexin Medi Solutions Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.86 Cr.
The company currently has active open charges totaling ₹10.00 Cr. The company has closed loans amounting to ₹6.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Keerthivasan, Anandkumar Sundharam, and Hariharan Parameswaran serve as directors at the Company.
- CIN/LLPIN
U74900PY2015PTC002951
- Company No.
002951
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Mar 2015
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pondicherry
Industry
Company Details
- Location
Pondicherry, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Linux Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Keerthivasan  | Director | 26-Aug-2019 | Current |
| Anandkumar Sundharam | Director | 26-Aug-2019 | Current |
| Hariharan Parameswaran | Director | 26-Aug-2019 | Current |
Financial Performance of Linux Life Sciences.
Linux Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 58.15% increase. The company also saw a substantial improvement in profitability, with a 118.95% increase in profit. The company's net worth moved up by a moderate rise of 1.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Linux Life Sciences?
In 2023, Linux Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Linux Laboratories Private LimitedActive 13 years 3 monthsKeerthivasan, Anandkumar Sundharam and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Feb 2023 | ₹10.00 Cr | Open |
Uco Bank Creation Date: 23 Mar 2016 | ₹6.50 Cr | Satisfied |
How Many Employees Work at Linux Life Sciences?
Linux Life Sciences has a workforce of 72 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Linux Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Linux Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
